StroMel for Osteoarthritis

Phase 1 & 2

Waitlist Available

Research Sponsored by Akan Biosciences, LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial is testing a new treatment for people with moderate to severe arthritis in their knee.

Eligible Conditions

Osteoarthritis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall Safety of StroMel

Safety of StroMel in subjects with moderate to severe OA of the kneee

Secondary outcome measures

Efficacy of StroMel in assessment of OA of the knee post-treatment

Efficacy of StroMel in managing OA of the knee

Trial Design

1Treatment groups

Experimental Treatment

Group I: Subjects with moderate to severe OA of the KneeExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Akan Biosciences, LLCLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criteria for this medical study include individuals below 45 years of age?

"According to the terms of enrollment, individuals must be between 25 and 65 years old in order to be included."

Answered by AI

Is there availability for those seeking to join this research?

"From the data collected on clinicaltrials.gov it appears that this medical experiment is not in search of any additional participants. The study was first published on August 22nd 2022 and has since been dormant, with no changes to its criteria or recruitment process as of July 30th 2022. Despite this, there are still 692 other trials looking for volunteers at present time."

Answered by AI

What are the eligibility requirements for taking part in this trial?

"Prospective applicants must meet the criteria of being between 25 and 65 years old and having knee-related issues in order to be accepted for this clinical trial, which has a capacity of 20 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Safety and Tolerability of StroMel™ in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint

2022. "Safety and Tolerability of StroMel™ in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04750252.